This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.

Topics:  real-time   delivered   news   breaking   
BING NEWS:
  • Novo Nordisk wins hard-fought FDA approval for once-daily hemophilia med Alhemo
    Undeterred by last year’s rejection and the recent approval of a close rival from Pfizer, Novo Nordisk has pushed its once-daily hemophilia injection across the regulatory finish line days before w | ...
    12/23/2024 - 1:33 am | View Link
  • Regulatory conditions on Novo Holdings' $16.5 billion Catalent deal fulfilled, companies say
    Dec 14 (Reuters) - All regulatory closing conditions related to Novo Holdings' $16.5 billion acquisition of U.S. contract drug maker ... the United States, to Novo Nordisk for $11 billion.
    12/13/2024 - 11:00 am | View Link
  • Novo Nordisk's Ozempic Label Expansion Snags Approval From European Drug Regulator's Advisory Panel
    Novo Nordisk's Ozempic gains positive EMA opinion for label update after FLOW trial data show significant kidney and cardiovascular risk reduction.
    12/12/2024 - 3:36 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News